News Image

Alumis to Participate in Upcoming September Investor Conferences

Provided By GlobeNewswire

Last update: Aug 29, 2025

SOUTH SAN FRANCISCO, Calif., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a late-stage biopharma company developing next-generation targeted therapies for patients with immune-mediated diseases, today announced that the Company will participate in the following investor conferences:

Read more at globenewswire.com

ALUMIS INC

NASDAQ:ALMS (10/17/2025, 8:00:00 PM)

After market: 4.5 +0.01 (+0.22%)

4.49

-0.12 (-2.6%)



Find more stocks in the Stock Screener

Follow ChartMill for more